Fundraising FoxMission Bay Capital — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US
Arnon Rosenthal(Ph.D.)inTillman Gerngross(Director)
BoardCarl Gordon(Director)Terry McGuire(Director)in
Co-investorsForesite CapitalGV (Google Ventures)Mission BiocapitalMRL Ventures FundSV Health InvestorsPolaris Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.